7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort

      research-article
      1 , 19 , , 19 , 10 , 10 , 6 , 5 , 9 , 14 , 1 , 17 , 11 , 14 , 16 , 10 , 18 , 7 , 9 , 16 , 1 , 4 , 1 , 8 , 1 , 9 , 9 , 4 , 15 , 12 , 9 , 1 , 4 , 16 , 3 , 16 , 10 , 11 , 4 , 11 , 9 , 9 , 2 , 2 , 13 , 9 , 10 , 15 , 11 , 12 , 10 , 9 , 10 , 1
      Pediatric Rheumatology Online Journal
      BioMed Central
      Juvenile arthritis, Growth, Obesity, Corticosteroids

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          With modern treatments, the effect of juvenile idiopathic arthritis (JIA) on growth may be less than previously reported. Our objective was to describe height, weight and body mass index (BMI) development in a contemporary JIA inception cohort.

          Methods

          Canadian children newly-diagnosed with JIA 2005–2010 had weight and height measurements every 6 months for 2 years, then yearly up to 5 years. These measurements were used to calculate mean age- and sex-standardized Z-scores, and estimate prevalence and cumulative incidence of growth impairments, and the impact of disease activity and corticosteroids on growth.

          Results

          One thousand one hundred forty seven children were followed for median 35.5 months. Mean Z-scores, and the point prevalence of short stature (height < 2.5th percentile, 2.5% to 3.4%) and obesity (BMI > 95th percentile, 15.8% to 16.4%) remained unchanged in the whole cohort. Thirty-three children (2.9%) developed new-onset short stature, while 27 (2.4%) developed tall stature (>97.5th percentile). Children with systemic arthritis ( n = 77) had an estimated 3-year cumulative incidence of 9.3% (95%CI: 4.3–19.7) for new-onset short stature and 34.4% (23–49.4) for obesity. Most children (81.7%) received no systemic corticosteroids, but 1 mg/Kg/day prednisone-equivalent maintained for 6 months corresponded to a drop of 0.64 height Z-scores (0.56–0.82) and an increase of 0.74 BMI Z-scores (0.56–0.92). An increase of 1 in the 10-cm physician global assessment of disease activity maintained for 6 months corresponded to a drop of 0.01 height Z-scores (0–0.02).

          Conclusions

          Most children in this modern JIA cohort grew and gained weight as children in the general population. About 1 in 10 children who had systemic arthritis, uncontrolled disease and/or prolonged corticosteroid use, had increased risk of growth impairment.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s12969-017-0196-7) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

          To develop preliminary criteria for inactive disease and clinical remission for select categories of juvenile idiopathic arthritis (JIA), and to decide what such clinical states should predict in terms of probability of disease recurrence. A Delphi serial questionnaire consensus-formation approach was used initially to gather criteria in use by pediatric rheumatologists (PR) for defining clinical remission in oligoarticular (persistent and extended), rheumatoid factor (RF) positive and negative polyarticular, and systemic JIA. Results from sequential questionnaires provided an agenda for a nominal group technique (NGT) conference to reach consensus on unresolved questions. One hundred and thirty PR from 34 countries responded to the questionnaires and 20 PR from 9 countries attended the conference. Draft criteria for inactive disease include the following: no active arthritis; no fever, rash, serositis, splenomegaly, or generalized lymphadenopathy attributable to JIA; no active uveitis; normal erythrocyte sedimentation rate or C-reactive protein; and a physician's global assessment of disease activity rated at the best score possible for the instrument used. According to consensus vote, 6 continuous months of inactive disease on medication defines clinical remission on medication, while 12 months of inactive disease off all anti-arthritis (and anti-uveitis) medications defines clinical remission off medication. The finalized criteria for remission off medication ideally should predict that a patient has
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey.

            The 2009 to 2011 Canadian Health Measures Survey provides the most recent measured body mass index (BMI) data for children and adolescents. However, different methodologies exist for classifying BMI among children and youth. Based on the most recent World Health Organization classification, nearly a third of 5- to 17-year-olds were overweight or obese. The prevalence of obesity differed between boys and girls (15.1% versus 8.0%), most notably those aged 5 to 11, among whom the percentage of obese boys (19.5%) was more than three times that of obese girls (6.3%). These estimates indicate a higher prevalence of overweight/obesity among children than do estimates based on International Obesity Task Force cut-offs. Although the prevalence of overweight and obesity among children in Canada has not increased over the last decade, it remains a public health concern, given the tendency for excess weight to persist through to adulthood and lead to negative health outcomes.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function.

                Bookmark

                Author and article information

                Contributors
                jguzman@cw.bc.ca
                kerr.tristan@gmail.com
                lward@cheo.on.ca
                jma@cheo.on.ca
                koen@mymts.net
                alan.rosenberg@usask.ca
                brian.feldman@sickkids.ca
                gilles.boire@usherbrooke.ca
                khoughton@cw.bc.ca
                paul.dancey@easternhealth.ca
                rosie.scuccimarri@muhc.mcgill.ca
                alessandra.bruns@usherbrooke.ca
                adam.huber@iwk.nshealth.ca
                kwatanabeduffy@cheo.on.ca
                natalie_shiff@hotmail.com
                roberta.berard@lhsc.on.ca
                deborah.levy@sickkids.ca
                elizabeth.stringer@iwk.nshealth.ca
                kmorishita@cw.bc.ca
                nicole.johnson@albertahealthservices.ca
                dcabral@cw.bc.ca
                mlarche@mcmaster.ca
                rpetty@cw.bc.ca
                ronald.laxer@sickkids.ca
                earl.silverman@sickkids.ca
                paivi.miettunen@albertahealthservices.ca
                anne-laure.chetaille@mail.chuq.qc.ca
                elie.haddad@umontreal.ca
                lynn.spiegel@sickkids.ca
                sturvey@bcchr.ca
                heinrike.schmeling@albertahealthservices.ca
                bianca.lang@iwk.nshealth.ca
                janet.ellsworth@albertahealthservices.ca
                Suzanne.Ramsey@iwk.nshealth.ca
                jroth@cheo.on.ca
                Sarah.Campillo@muhc.mcgill.ca
                Susanne.Benseler@albertahealthservices.ca
                Gaelle.Chedeville@muhc.mcgill.ca
                Rayfel.Schneider@sickkids.ca
                Shirley.Tse@sickkids.ca
                Rox@Bolaria.org
                KGross@shaw.ca
                Debbie.Feldman@umontreal.ca
                Bonnie.Cameron@sickkids.ca
                RJurencak@cheo.on.ca
                Jean.Dorval@ens.chuq.qc.ca
                Claire.LeBlanc@muhc.mcgill.ca
                Claire.StCyr@umontreal.ca
                MGibbon@cheo.on.ca
                rae.yeung@sickkids.ca
                CDuffy@cheo.on.ca
                LTucker@cw.bc.ca
                Journal
                Pediatr Rheumatol Online J
                Pediatr Rheumatol Online J
                Pediatric Rheumatology Online Journal
                BioMed Central (London )
                1546-0096
                22 August 2017
                22 August 2017
                2017
                : 15
                : 68
                Affiliations
                [1 ]ISNI 0000 0001 2288 9830, GRID grid.17091.3e, , From British Columbia Children’s Hospital and University of British Columbia, ; Vancouver, Canada
                [2 ]ISNI 0000 0001 2288 9830, GRID grid.17091.3e, , Department of Pediatrics University of British Columbia, ; Vancouver, Canada
                [3 ]ISNI 0000 0004 0633 3703, GRID grid.416656.6, , Stollery Children’s Hospital and University of Alberta, ; Edmonton, Canada
                [4 ]ISNI 0000 0001 0684 7358, GRID grid.413571.5, , Alberta Children’s Hospital and University of Calgary, ; Calgary, Canada
                [5 ]ISNI 0000 0004 0462 8356, GRID grid.412271.3, , Royal University Hospital and University of Saskatchewan, ; Saskatoon, Canada
                [6 ]ISNI 0000 0004 1936 9609, GRID grid.21613.37, Department of Pediatrics and Child Health, , University of Manitoba, ; Winnipeg, Canada
                [7 ]ISNI 0000 0000 9132 1600, GRID grid.412745.1, , London Health Sciences Centre and Western University, ; London, Canada
                [8 ]ISNI 0000 0004 1936 8227, GRID grid.25073.33, , McMaster University, ; Hamilton, Canada
                [9 ]ISNI 0000 0004 0473 9646, GRID grid.42327.30, , Hospital for Sick Children and University of Toronto, ; Toronto, Canada
                [10 ]ISNI 0000 0000 9402 6172, GRID grid.414148.c, , Children’s Hospital of Eastern Ontario and University of Ottawa, ; Ottawa, Canada
                [11 ]ISNI 0000 0000 9064 4811, GRID grid.63984.30, , McGill University Health Centre and McGill University, ; Montreal, Canada
                [12 ]ISNI 0000 0001 2292 3357, GRID grid.14848.31, , Centre Hospitalier Universitaire Ste. Justine and Université de Montréal, ; Montréal, Canada
                [13 ]ISNI 0000 0001 2292 3357, GRID grid.14848.31, , Université de Montréal, ; Montréal, Canada
                [14 ]ISNI 0000 0001 0081 2808, GRID grid.411172.0, , Centre Hospitalier Universitaire de Sherbrooke and Université de Sherbrooke, ; Sherbrooke, Canada
                [15 ]Centre Hospitalier Universitaire de Laval and Université Laval, Quebec, Canada
                [16 ]IWK Health Centre and Dalhousie University, Halifax, Canada
                [17 ]GRID grid.477424.6, , Janeway Children’s Health and Rehabilitation Centre and Memorial University, ; Saint John, ’s Canada
                [18 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, , Shands Children’s Hospital and University of Florida, ; Gainesville, USA
                [19 ]ISNI 0000 0001 0684 7788, GRID grid.414137.4, , Division of Pediatric Rheumatology, BC Children’s Hospital, ; 4500 Oak St, Suite K4-122, Vancouver, BC V6H 3N1 Canada
                Author information
                http://orcid.org/0000-0001-8977-2581
                Article
                196
                10.1186/s12969-017-0196-7
                5567720
                28830457
                041290f3-5041-4c15-a65d-67322f2836aa
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 13 May 2017
                : 14 August 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000024, Canadian Institutes of Health Research;
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2017

                Pediatrics
                juvenile arthritis,growth,obesity,corticosteroids
                Pediatrics
                juvenile arthritis, growth, obesity, corticosteroids

                Comments

                Comment on this article